Compare Stocks

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DPM Dundee Precious Metals	C$10.73 +0.4%	C$9.64	C$7.79 ▼ C$10.94	C$1.95B	1.2	575,197 shs	369,823 shs
EQX Equinox Gold	$5.86 -0.3%	$0.00	$3.95 ▼ $6.50	$1.93B	1.32	2.35 million shs	1.38 million shs
NGD New Gold	$1.75 +1.2%	$0.00	$0.86 ▼ $1.94	$1.21B	1.54	6.23 million shs	7.37 million shs
TXG 10x Genomics	$28.95 -0.7%	$40.19	$26.75 ▼ $63.57	$3.45B	1.9	1.46 million shs	2.96 million shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DPM Dundee Precious Metals	+1.42%	+2.10%	+6.37%	+28.64%	+3.69%
EQX Equinox Gold	0.00%	0.00%	0.00%	-12.40%	-22.34%
NGD New Gold	0.00%	0.00%	0.00%	0.00%	-22.43%
TXG 10x Genomics	-5.32%	-17.42%	-19.18%	-30.59%	-46.48%

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DPM Dundee Precious Metals	4.1609 of 5 stars	3.5	0.0	1.7	0.0	4.1	2.5	2.5
EQX Equinox Gold	3.1826 of 5 stars	0.0	4.0	0.0	0.0	3.9	0.0	3.8
NGD New Gold	1.1463 of 5 stars	1.0	3.0	0.0	0.0	2.5	0.8	3.1
TXG 10x Genomics	4.1506 of 5 stars	3.4	2.0	0.0	4.8	2.3	3.3	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DPM Dundee Precious Metals	3.00	Buy	C$13.53	26.11% Upside
EQX Equinox Gold	2.50	Moderate Buy	N/A	N/A
NGD New Gold	2.00	Hold	$1.64	-6.29% Downside
TXG 10x Genomics	2.88	Moderate Buy	$60.22	108.02% Upside

Current Analyst Ratings

Latest NGD, TXG, EQX, and DPM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/18/2024	TXG 10x Genomics	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$60.00 ➝ $55.00
4/15/2024	DPM Dundee Precious Metals	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target		C$11.50 ➝ C$13.00
4/10/2024	TXG 10x Genomics	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$55.00 ➝ $45.00
4/8/2024	EQX Equinox Gold	National Bank Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform Spec Overwgt
4/8/2024	NGD New Gold	National Bank Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform Spec Overwgt
4/8/2024	NGD New Gold	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$1.65 ➝ $2.00
2/29/2024	DPM Dundee Precious Metals	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy	C$13.00
2/16/2024	TXG 10x Genomics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$68.00 ➝ $63.00
2/15/2024	DPM Dundee Precious Metals	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$13.50 ➝ C$13.25
1/30/2024	EQX Equinox Gold	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
1/25/2024	TXG 10x Genomics	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$45.00 ➝ $55.00

(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DPM Dundee Precious Metals	C$520.09M	3.74	C$3.85 per share	2.79	C$6.18 per share	1.74
EQX Equinox Gold	$1.09B	1.78	$0.75 per share	7.80	$7.68 per share	0.76
NGD New Gold	$786.50M	1.53	$0.42 per share	4.17	$1.15 per share	1.52
TXG 10x Genomics	$618.73M	5.58	N/A	N/A	$6.22 per share	4.65

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DPM Dundee Precious Metals	C$181.98M	C$1.33	8.07	∞	0.04	37.10%	17.22%	9.53%	5/7/2024 (Confirmed)
EQX Equinox Gold	$28.88M	$0.09	65.11	10.85	N/A	2.65%	0.69%	0.40%	N/A
NGD New Gold	-$64.50M	-$0.09	N/A	9.21	0.91	-8.20%	5.63%	2.15%	N/A
TXG 10x Genomics	-$255.10M	-$2.17	N/A	N/A	N/A	-41.17%	-28.82%	-22.67%	4/30/2024 (Confirmed)

Latest NGD, TXG, EQX, and DPM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2024	N/A	DPM Dundee Precious Metals	N/A	N/A	N/A	N/A	N/A	N/A
4/30/2024	N/A	TXG 10x Genomics	-$0.46	N/A	+$0.46	N/A	N/A	N/A
2/21/2024	12/31/2023	EQX Equinox Gold	-$0.02	$0.01	+$0.03	$0.01	N/A	$297.80 million
2/15/2024	Q4 2023	TXG 10x Genomics	-$0.36	-$0.41	-$0.05	-$0.41	$182.73 million	$183.98 million
2/14/2024	Q4 2023	DPM Dundee Precious Metals	C$0.48	C$0.38	-C$0.10	C$0.32	N/A	C$189.66 million
2/13/2024	Q4 2023	NGD New Gold	$0.02	-$0.01	-$0.03	$0.02	N/A	$199.20 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DPM Dundee Precious Metals	C$0.22	2.05%	N/A	16.54%	N/A
EQX Equinox Gold	N/A	N/A	N/A	N/A	N/A
NGD New Gold	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	N/A	N/A	N/A	N/A	N/A

Latest NGD, TXG, EQX, and DPM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/14/2024	DPM Dundee Precious Metals	Quarterly	C$0.05	2.57%	3/27/2024	3/31/2024	4/15/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DPM Dundee Precious Metals	0.28	6.70	6.61
EQX Equinox Gold	0.32	1.74	0.88
NGD New Gold	0.51	1.54	0.98
TXG 10x Genomics	N/A	4.69	4.11

Ownership

Institutional Ownership

Company	Institutional Ownership
DPM Dundee Precious Metals	63.89%
EQX Equinox Gold	38.85%
NGD New Gold	42.82%
TXG 10x Genomics	84.68%

Insider Ownership

Company	Insider Ownership
DPM Dundee Precious Metals	0.11%
EQX Equinox Gold	8.35%
NGD New Gold	0.20%
TXG 10x Genomics	10.65%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DPM Dundee Precious Metals	147,000	181.43 million	N/A	Not Optionable
EQX Equinox Gold	3,692	329.80 million	302.26 million	Not Optionable
NGD New Gold	1,578	689.60 million	688.22 million	Not Optionable
TXG 10x Genomics	1,259	119.17 million	106.48 million	Optionable

NGD, TXG, EQX, and DPM Headlines

Source	Headline
	Bruker to acquire Nanostring for $393M medtechdive.com - April 18 at 3:02 PM
	10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst Downgrade marketbeat.com - April 18 at 10:35 AM
	10x Genomics (NASDAQ:TXG) PT Lowered to $55.00 marketbeat.com - April 18 at 8:34 AM
	10x Genomics, Inc. (TXG) finance.yahoo.com - April 17 at 12:34 PM
	10x Genomics (NASDAQ:TXG) Trading Down 5.9% marketbeat.com - April 16 at 1:41 PM
	10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc. marketbeat.com - April 16 at 7:22 AM
	SVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) marketbeat.com - April 15 at 10:06 PM
	10x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.47 marketbeat.com - April 15 at 2:48 PM
	10x Genomics (NASDAQ:TXG) Shares Gap Down After Analyst Downgrade americanbankingnews.com - April 12 at 5:26 AM
	Cathie Wood's ARK focuses on Teladoc and 10X Genomics stock investing.com - April 11 at 7:21 PM
	10x Genomics (NASDAQ:TXG) Price Target Cut to $45.00 by Analysts at Barclays americanbankingnews.com - April 11 at 4:58 AM
	10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 finance.yahoo.com - April 10 at 7:03 PM
	10x Genomics (NASDAQ:TXG) Price Target Cut to $45.00 marketbeat.com - April 10 at 4:19 PM
	10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 prnewswire.com - April 10 at 4:05 PM
	10x Genomics (NASDAQ:TXG) Shares Gap Down to $37.37 marketbeat.com - April 10 at 11:50 AM
	Baillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG) marketbeat.com - April 9 at 12:12 PM
	As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers? genengnews.com - March 29 at 5:58 PM
	ARK Investment Management LLC Acquires 1,047,827 Shares of 10x Genomics, Inc. (NASDAQ:TXG) marketbeat.com - March 28 at 6:39 AM
	10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Vanguard Group Inc. marketbeat.com - March 27 at 4:25 AM
	10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay finance.yahoo.com - March 26 at 1:11 PM
	10x Genomics, Inc: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel finanznachrichten.de - March 23 at 12:22 PM
	10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel finance.yahoo.com - March 21 at 4:46 PM
	TXG Nov 2024 40.000 put ca.finance.yahoo.com - March 16 at 2:48 PM
	TXG Aug 2024 60.000 call ca.finance.yahoo.com - March 16 at 1:47 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Dundee Precious Metals

TSE:DPM

Dundee Precious Metals Inc., a gold mining company, engages in the acquisition, exploration, development, mining, and processing of precious metals. The company primarily explores for gold, copper, and silver deposits. It holds a portfolio of projects located in Bulgaria, Namibia, Serbia, and Ecuador. The company is based in Toronto, Canada.

Equinox Gold

NYSEAMERICAN:EQX

Equinox Gold Corp. engages in the exploration, acquisition, development, and operation of mineral properties in the Americas. It explores gold and silver deposits. It holds interest in properties in California located in the United States; Guerrero State located in Mexico; Maranhão, Bahia, and Mina Gerais state located in Brazil; and Ontario, Canada. The company was formerly known as Trek Mining Inc. and changed its name to Equinox Gold Corp. in December 2017. Equinox Gold Corp. was incorporated in 2007 and is headquartered in Vancouver, Canada.

New Gold

NYSEAMERICAN:NGD

New Gold Inc., an intermediate gold mining company, develops and operates of mineral properties in Canada. It primarily explores for gold, silver, and copper deposits. The company's principal operating properties include 100% interest in the Rainy River mine located in Northwestern Ontario, Canada; and New Afton project situated in South-Central British Columbia. New Gold Inc. is headquartered in Toronto, Canada.

10x Genomics

NASDAQ:TXG

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial